To see all protocols that comply with the WHO Essential Medicine List 
This fact sheet contains general information about Neurofibromatosis type 2 (NF2). Each person should be referred to a genetic service for further information and advice.

Key Points

  • NF2 is caused by faults (mutations) in the NF2 gene.
  • People with NF2 have an increased chance of developing benign (non-cancerous) tumours of the coverings of the nerves and brain (called schwannomas and meningiomas).
  • People with NF2 have an increased chance of developing benign tumours of the spinal cord.
  • People with NF2 have an increased chance of developing eye, skin and nerve problems.
  • Family members (including infants and children) can be referred to a genetic service where experts can provide information, advice and support about their chance of developing benign tumours and the option of genetic testing.   

This cancer genetics fact sheet is a guide only and cannot cover every possible situation. The information provided is not intended to replace discussion with a health professional, and should not be interpreted as medical advice. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information sources. Use of this document is subject to eviQ's disclaimer available at www.eviQ.org.au/copyright  

Send feedback for this page


First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/3450

29 Mar 2024